26325 Investors following HPCL. Share this News with them.
0
Like this story, share it with millions of investors on M3
Stocks in news: Hulta Pharma, Pratibha Inds, Blue Bird,
Stocks in news: Hulta Pharma has board meet to consider issuing further shares on a rights basis. Pratibha Industries has bagged order worth Rs 44.75 cr from Delhi Jal Board. Blue Bird has received a US$ 4.4 mn. export order.
Board Meet: Hulta Pharma to consider issuing further shares on a rights basis Madras Aluminium to consider restructuring business Pioneer Embroideries to submit financial restructuring plan to lenders
Ex - Div: RCF ( Rs 1 ), IOC (Rs 5.5) , IVRCL Infrastructure ( Rs 1.4) and Hero Honda( Rs 19)
EX Rights: Tata Motors (Rights Eq 1:6/Dif Vot 1:6)
Tata Motors continues to suspend work at Singur
WB Govt Sources Say Nano might not come out of Singur plant Strong possibility of Nano project being shelved Land review panel not likely to find solution
Tata Sources Say Tata wanted to come in before final agreement Not consulted before agreement finalised Only 47 acres govt land in plant for review 997 acres critical for plant to be functional Ancillary units, mother plant cannot be separated
HCL Tech may bid 15% higher for Axon - ET
Unitech raises Rs 1200 cr debt for its telecom venture from banks lead by PNB and Canara BK - ET
Vedanta to rejig India operations, likely to merge Malco with Sterlite - ET
GSK Pharma sues Lupin for infringing Combivir Patent in US: pharmaasianews.com (Alert: Combivir worldwide patent expires in 2012)
DLF buyback gets Sebi approval, buy back price at Rs 600/sh
